New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can increase the risk of recurrent infections.
Click here for original story, Nanosilver is not a ‘silver bullet’ in long-term treatment of infections
Source: Phys.org